MarketLens
Sign Up

Has Madrigal Pharmaceuticals (MDGL) Cracked the Code for MASH

7 months ago
SHARE THIS ON:

Has Madrigal Pharmaceuticals (MDGL) Cracked the Code for MASH

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off

Madrigal Pharmaceuticals' stock could take off if Rezdiffra expands into MASH cirrhosis, significantly enlarging its addressable market, while its developing pipeline may reduce dependence on the drug...
Stock News•2 months ago

Madrigal (MDGL) Reports Q2 Loss, Beats Revenue Estimates

Madrigal (MDGL) reported a Q2 loss of $1.99 per share, beating the Zacks Consensus Estimate of a $2.55 loss, though wider than the $1.9 loss a year ago.
Stock News•3 months ago

Helus Pharma: APPROACHing Inflection: Pivotal Readout Sets Up Asymmetric Upside

Helus Pharma's valuation (~$269M EV) under-credits HLP003's probability-weighted value, with a risk-adjusted implied EV of ~$1.5B if Phase 3 succeeds. The pivotal APPROACH readout in Q4 2026 sets up a...

Breaking News

View All →

Top Headlines

View More →
Stock News•49 minutes ago

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•1 hour ago

Prediction: Alphabet Will Soar After Oct. 28

Stock News•1 hour ago

Alphabet (GOOGL) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News•1 hour ago

Why Alphabet Inc. (GOOG) Dipped More Than Broader Market Today

Stock News•2 hours ago

OpenAI claims ex-employee brought confidential docs about ‘unreleased device' to Apple